Latest News for: gimv

Edit

Gimv sells majority stake in ALT Technologies to CCL Industries (GIMV NV)

Public Technologies 16 Jan 2026
GIMV ... Gimv ... GIMV ... GIMV NV published this content on January 16, 2026, and is solely responsible for the information contained ...
Edit

Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries (GIMV NV)

Public Technologies 16 Jan 2026
GIMV ... Gimv ... GIMV ... GIMV NV published this content on January 16, 2026, and is solely responsible for the information contained ...
Edit

Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors (GIMV NV)

Public Technologies 12 Jan 2026
) ... The study has received regulatory approval in the United States and Australia ... Kivu is headquartered in San Mateo, CA ... Media Contact ... GIMV NV published this content on January 12, 2026, and is solely responsible for the information contained herein.
Edit

Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases (GIMV NV)

Public Technologies 12 Jan 2026
Bram Vanparys, Managing Director - Head of Life Sciences at Gimv comments ... and Gimv ... GIMV NV published this content on January 12, 2026, and is solely responsible for the information contained herein.
Edit

Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD (GIMV NV)

Public Technologies 08 Jan 2026
). FDA Fast Track designation has been granted to CTx001 for Geographic Atrophy secondary to Age-related Macular Degeneration ... GIMV NV published this content on January 08, 2026, and is solely responsible for the information contained herein ... (noodl.
Edit

Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio (GIMV NV)

Public Technologies 07 Jan 2026
). Series B Co-led by New Investors Amplitude Ventures and ICG ... Andreas Jurgeit, PhD, Partner in Gimv's Life Sciences team comments ... GIMV NV published this content on January 07, 2026, and is solely responsible for the information contained herein.
Edit

Cegeka Strengthens Board of Directors to Accelerate Growth and International Expansion (GIMV NV)

Public Technologies 05 Dec 2025
Bart Troubleyn serves as Head of Anchor Investments, the investment initiative of Gimv and WorxInvest focused on building long-term partnerships with ambitious growth companies ... Before joining Gimv, he ...
Edit

Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA (GIMV NV)

Public Technologies 02 Dec 2025
). U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPA ... GIMV NV published this content on December 02, 2025, and is solely responsible for the information contained herein ... (noodl.
Edit

Gimv bundelt krachten met CNP om de wereldwijde expansie van Equine Care Group te versnellen (GIMV NV)

Public Technologies 27 Nov 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on November 27, 2025, and is solely responsible for the information contained ...
Edit

Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group (GIMV NV)

Public Technologies 27 Nov 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on November 27, 2025, and is solely responsible for the information contained ...
Edit

Solid growth performance in the first half of FY 2025 (GIMV NV)

Public Technologies 20 Nov 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on November 20, 2025, and is solely responsible for the information contained herein ...
Edit

Solide groei in eerste helft boekjaar 2025 (GIMV NV)

Public Technologies 20 Nov 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on November 20, 2025, and is solely responsible for the information contained ...
Edit

EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide (GIMV NV)

Public Technologies 31 Oct 2025
). U.S. Environmental Protec3on Agency Ini3ates Public Par3cipa3on Procedure ... Attachments Original document Permalink. Disclaimer. GIMV NV published this content on October 31, 2025, and is solely responsible for the information contained herein ... (noodl.
Edit

Gimv Life Sciences realiseert succesvolle exit met de verkoop van belang in Imcheck Therapeutics aan Ipsen. (GIMV NV)

Public Technologies 22 Oct 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on October 22, 2025, and is solely responsible for the information contained ...
Edit

Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen (GIMV NV)

Public Technologies 22 Oct 2025
GIMV ... Gimv ... GIMV ... GIMV NV published this content on October 22, 2025, and is solely responsible for the information contained ...

Article Search

tools
×
×
×
×